

Clinical Case of Acute Analgesic Nephropathy in a 14-Year-Old Child
https://doi.org/10.33667/2078-5631-2023-23-62-66
Abstract
Medications are responsible for more than a quarter of cases of acute kidney failure (AKF) in both outpatient and hospital practice. This is often due to underestimating the safety of prescribed drugs, the over-the-counter availability of medications, insufficient justification for prescriptions, and uncontrolled use. In 70–90 % of cases, acute drug-induced kidney damage presents as acute tubulointerstitial nephritis (ATIN), with a mortality rate of around 10 %. This article presents a case of acute kidney injury in a teenage girl following the use of sodium metamizole during the postoperative period. The timely application of two hemodialysis sessions helped avoid disaster, and subsequent monitoring of the patient (enalapril 2.5 mg twice daily, levocarnitine 20 % 1 teaspoon twice daily, dietary restrictions) over nearly two years showed slow recovery of kidney function, which indicates the severe nature of the kidney damage.
About the Authors
N. V. TeplovaRussian Federation
Teplova Natalia V., DM Sci (habil.), professor, head of Dept of Clinical Pharmacology, Institute of Clinical Medicine
Moscow
S. S. Postnikov
Russian Federation
Postnikov Sergey S., DM Sci (habil.), professor at Department of Clinical Pharmacology, Institute of Clinical Medicine
Moscow
J. D. Tramova
Russian Federation
Tramova Zhanetta D., physician of Dept of Reconstructive and Thoracic Surgery
Moscow
E. K. Petrosyan
Russian Federation
Petrosyan Edita K., DM Sci (habil.), professor at Dept of Hospital Pediatrics named after V. A. Tabolin, Institute of Maternity and Childhood, head of Nephrology Dept
Moscow
M. N. Kostyleva
Russian Federation
Kostyleva Maria N., PhD Med, associate professor at Dept of Clinical Pharmacology, Institute of Clinical Medicine, head the Dept of Clinical Pharmacology
Moscow
A. N. Grazzianskaya
Russian Federation
Gratsianskaya Anna N., PhD Med, associate professor at Dept of Clinical Pharmacology, Institute of Clinical Medicine
Moscow
L. B. Belousova
Russian Federation
Belousova Lyudmila B., 6th-year student of the Faculty of Pediatrics
Moscow
D. Yu. Dalakyan
Russian Federation
Dalakyan Daria Yu., 6th year student of the pediatric faculty
Moscow
References
1. Dadyk A. I., Kugler T. E. Drug-induced acute tubulointerstitial nephritis // Almanac of Clinical Medicine. – 2017. – Vol. 45. – No 7. – P. 586–598.
2. Naughton C. A. Drug-induced nephrotoxicity // American family physician. – 2008. – Т. 78. – № 6. – С. 743–750.
3. Putilina M. V., Teplova N. V. Drug safety as a priority direction in domestic medicine / M. V. Putilina, N. V. Teplova // Therapeutic Affairs. – 2019. – No 4. – P. 7–14. – DOI 10.24411/2071–5315–2019–12152. – EDN RSQEWX
4. Garcia M. et al. Inadequate drug prescription and the rise in drug-induced acute tubulointerstitial nephritis incidence // NDT plus. – 2010. – Т. 3. – № 6. – С. 555–557.
5. Glanzmann C. et al. Drugs as risk factors of acute kidney injury in critically ill children // Pediatric Nephrology. – 2016. – Т. 31. – С. 145–151.
6. Astakhova A. V., Toropova I. A., Darmostukova M. A. Analysis of reports on adverse reactions to sodium metamizole (Analgin, Dipyrone) received at the Center // Drug Safety and Pharmacovigilance. – 2011. – No 1. – P. 26–29.
7. Stueber T. et al. The use of dipyrone in the ICU is associated with acute kidney injury // European Journal of Anaesthesiology. – 2017. – Т. 34. – № 10. – С. 673–680.
8. Shishkin A. N. Drug-induced nephropathy // Russian Family Doctor. – 2005. – Vol. 9. – No 4. – P. 10–14.
9. Choudhury D., Ahmed Z. Drug-associated renal dysfunction and injury // Nature clinical practice Nephrology. – 2006. – Т. 2. – № 2. – С. 80–91.
10. Onay O. S. et al. Acute, reversible nonoliguric renal failure in two children associated with analgesic-antipyretic drugs // Pediatric emergency care. – 2009. – Т. 25. – № 4. – С. 263–266.
11. Dudareva L. A., Batyushin M. M. Chronic tubulointerstitial nephritis induced by the use of nonsteroidal anti-inflammatory drugs: epidemiological features and possibilities of early diagnosis // Nephrology. – 2013. – Vol. 17. – No 5. – P. 22–26.
12. Etiological and pathogenic factors in the development of hypertensive crises in patients with primary arterial hypertension / V. A. Lyusov, E. M. Evsikov, Yu. M. Mashukova [et al.] // Russian Journal of Cardiology. – 2008. – Vol. 13, No 4. – P. 5–15. – EDN JSIJFP.
13. Hassan K. et al. Acute kidney injury associated with metamizole sodium ingestion // Renal failure. – 2011. – Т. 33. – № 5. – С. 544–547.
14. Belousov Yu. B., Gurevich K. G., Chausova S. V. OTC analgesics-antipyretics for oral use: mechanism of action and safety profile. – Treating Doctor. – 201?. – No 1. – P. 79–82.
15. Zapater P. et al. Acute effects of dipyrone on renal function in patients with cirrhosis: a randomized controlled trial // Basic & clinical pharmacology & toxicology. – 2015. – Т. 116. – № 3. – С. 257–263.
16. Pierre S. C. et al. Inhibition of cyclooxygenases by dipyrone // British journal of pharmacology. – 2007. – Т. 151. – № 4. – С. 494–503.
17. Pannu N., Nadim M. K. An overview of drug-induced acute kidney injury // Critical care medicine. – 2008. – Т. 36. – № 4. – С. S 216-S 223.
18. Sandys V., Byrne D. Acute interstitial nephritis secondary to metamizole; the rise of drug tourism // Irish medical journal. – 2016. – Т. 109. – № 7. – С. 445.
19. Berruti V. et al. Noramidopyrine (Metamizol) and acute interstitial nephritis // Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. – 1998. – Т. 13. – № 8. – С. 2110–2112.
20. Kötter T. et al. Metamizole-associated adverse events: a systematic review and meta-anal-ysis // PloS one. – 2015. – Т. 10. – № 4. – С. e0122918.
21. Krause I. et al. Acute renal failure, associated with non-steroidal anti-inflammatory drugs in healthy children // Pediatric Nephrology. – 2005. – Т. 20. – С. 1295–1298.
22. Redondo-Pachon M. D. et al. Acute renal failure and severe thrombocytopenia associated with metamizole // Saudi Journal of Kidney Diseases and Transplantation. – 2014. – Т. 25. – № 1. – С. 121.
23. Syraeva G. I., Kolbin A. S. Adverse drug reactions to nonsteroidal anti-inflammatory drugs: data from the national database over 10 years // Quality Clinical Practice. – 2021. – No 4. – P. 16–26.
24. Erinc K. et al. Bone marrow suppression and acute renal failure related to single dose of 500 milligram dipyrone // Case Rep Clin Pract Rev. – 2003. – Т. 4. – № 2. – С. 94–96.
25. Vlahov V. et al. Genetic factors and risk of agranulocytosis from metamizol // Pharmacogenetics and Genomics. – 1996. – Т. 6. – № 1. – С. 67–72.
26. Teplova N. V. Correction of endothelial dysfunction in COVID-19 / N. V. Teplova, D. V. Grishin // Medical Alphabet. – 2020. – No 22. – P. 56–59. – DOI 10.33667/2078-5631-2020-22-56-59.
27. The effectiveness and safety of Cytoflavin in the rehabilitation of patients with post-COVID syndrome: results of the prospective randomized study CITADEL / M. V. Putilina, N. V. Teplova, K. I. Bairova [et al.] // Journal of Neurology and Psychiatry named after S. S. Korsakov. – 2021. – Vol. 121, No 10. – P. 45–51. – DOI 10.17116/jnevro202112110145.
28. Kovalenko L. A. et al. Experience in the use of a cellular energy protector in the complex treatment of acute kidney injury in a teenager with sodium metamizole poisoning // Pediatrics. Journal named after G. N. Speransky. – 2021. – Vol. 100. – No 3. – P. 283–289.
29. Dhodi D. K. et al. Drug-induced nephrotoxicity. – 2014. – Vol. 3. – C. 591–597.
Review
For citations:
Teplova N.V., Postnikov S.S., Tramova J.D., Petrosyan E.K., Kostyleva M.N., Grazzianskaya A.N., Belousova L.B., Dalakyan D.Yu. Clinical Case of Acute Analgesic Nephropathy in a 14-Year-Old Child. Medical alphabet. 2024;(23):62-66. (In Russ.) https://doi.org/10.33667/2078-5631-2023-23-62-66